Trial Profile
Efficacy of Glycaemic Control of Biphasic Insulin Aspart (NovoMix 30 [insulin aspart/insulin protamine aspart]) or Insulin Detemir (Levemir) in Patients With Type 1 or 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2024
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin detemir (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 08 Oct 2008 Actual patient number (400) added as reported by ClinicalTrials.gov.
- 08 Oct 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 08 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.